Sickle Cell Disease Trial, Recruiting NCT06184126 Sponsor: University of Maryland, Baltimore Condition: Sickle Cell Disease
Back to Sickle Cell Disease

Sickle Cell Disease Trial, Recruiting

NCT06184126
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults over 18 years old who are being seen in an emergency department
  • People who have been diagnosed with sickle cell disease
  • People who came to the emergency department because of severe pain from sickle cell disease, specifically a type of pain episode called a vaso-occlusive crisis

Who may not be able to join:

  • People who have already taken part in this study before
  • People whose pain episode appears to involve serious complications — such as problems with the lungs, spleen, or liver, or a possible blood clot — as judged by the treating doctor
  • People who are not receiving opioid pain medication through an intravenous (IV) drip for their pain episode
  • People who are not able to give informed consent for themselves
  • People with a history of seizures, or who are known to have had a bad reaction to virtual reality
  • People with vision, hearing, or other difficulties that would prevent them from wearing a virtual reality headset
  • People who are known to be pregnant
  • People who are currently incarcerated at the time of their emergency department visit
  • People over the age of 89

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: R. Gentry Wilklerson, MD, U of Maryland, Baltimore

Phone: 410-328-4237

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
30 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Comparison of the change in pain scores between the 3 groups at one hour after completion of the study intervention.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov